research Severe Pustular Drug Eruptions From Amivantamab: A Case Series 1 citations , January 2026 in “International Journal of Dermatology” Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.
research P164 Cutaneous toxicities occurring during amivantamab treatment: the experience of a single large specialist institution June 2026 in “British Journal of Dermatology” Amivantamab treatment often causes skin issues that can affect quality of life and treatment continuation.